Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. LFST
stocks logo

LFST

-
Add to WatchlistAdvanced Chart
$
0.000
0(0.000%)1D
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
348.71M
+11.65%
--
--
359.13M
+14.84%
--
--
372.84M
+14.54%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for LifeStance Health Group, Inc. (LFST) for FY2025, with the revenue forecasts being adjusted by -0.23% over the past three months. During the same period, the stock price has changed by -31.49%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.23%
In Past 3 Month
Stock Price
Go Down
down Image
-31.49%
In Past 3 Month
6 Analyst Rating
up Image0
Wall Street analysts forecast LFST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFST is 8.70 USD with a low forecast of 8.00 USD and a high forecast of 10.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
1 Hold
0 Sell
Strong Buy
up Image0
Current: 4.220
sliders
Low
8.00
Averages
8.70
High
10.00
up Image0
Current: 4.220
sliders
Low
8.00
Averages
8.70
High
10.00
UBS
Kevin Caliendo
Neutral -> Buy
upgrade
$8.50
2025-05-27
Reason
UBS
Kevin Caliendo
Price Target
$8.50
2025-05-27
upgrade
Neutral -> Buy
Reason
Keybanc
Steve Dechert
Buy
Initiates
$9
2025-04-08
Reason
Keybanc
Steve Dechert
Price Target
$9
2025-04-08
Initiates
Buy
Reason
KeyBanc initiated coverage of LifeStance with an Overweight rating and $9 price target. The firm expects mid-teens organic sales growth over the next couple of years from the company, driven mainly by higher visit volumes on further clinician adds and increasing total revenue per visit on payor reimbursement rate improvement. It also expects margin expansion on the company's recently optimized real estate footprint, clinician productivity, higher margin specialty offerings, and continued cost efficiencies driven by technology enhancements.
Canaccord Genuity
Richard Close
Strong Buy
Initiates
$8
2025-04-03
Reason
Canaccord Genuity
Richard Close
Price Target
$8
2025-04-03
Initiates
Strong Buy
Reason
Canaccord analyst Richard Close initiated coverage of LifeStance with a Buy rating and $8 price target. LifeStance is the largest clinic-based therapy provider, serving its clients both through in-person and virtual visits, the analyst tells investors in a research note. The firm says the company offers the only hybrid, in-person and virtual therapy company to invest in. It believes LifeStance's acquisition strategy offers growth upside.
Goldman Sachs
Jamie Perse
Hold
to
Strong Buy
Upgrades
$10
2024-12-16
Reason
Goldman Sachs
Jamie Perse
Price Target
$10
2024-12-16
Upgrades
Hold
to
Strong Buy
Reason
Barclays
Stephanie Davis
Sell
Maintains
$6 → $7
2024-11-11
Reason
Barclays
Stephanie Davis
Price Target
$6 → $7
2024-11-11
Maintains
Sell
Reason
UBS
Kevin Caliendo
Hold
Maintains
$9 → $7.5
2024-08-15
Reason
UBS
Kevin Caliendo
Price Target
$9 → $7.5
2024-08-15
Maintains
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for LifeStance Health Group Inc (LFST.O) is -113.11, compared to its 5-year average forward P/E of -31.83. For a more detailed relative valuation and DCF analysis to assess LifeStance Health Group Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-31.83
Current PE
-113.11
Overvalued PE
-3.10
Undervalued PE
-60.56

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average EV/EBITDA
48.06
Current EV/EBITDA
14.34
Overvalued EV/EBITDA
81.60
Undervalued EV/EBITDA
14.51

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
3.11
Current PS
1.17
Overvalued PS
5.40
Undervalued PS
0.81

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders areSelling! The selling amount has increased 318.77% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 318.77% over the last month.
Sold
Bought

LFST News & Events

Events Timeline

(ET)
2025-05-14
09:01:42
LifeStance appoints Vaughn Paunovich as CTO
select
2025-05-07 (ET)
2025-05-07
06:07:23
LifeStance still sees 2025 revenue $1.40B-$1.44B, consensus $1.42B
select
2025-05-07
06:05:54
LifeStance reports Q1 EPS 0c vs. (6c) last year
select
Sign Up For More Events
Sign Up For More Events

News

Preview
4.0
06-27NASDAQ.COM
LifeStance Health (LFST) Upgraded to Strong Buy: What Does It Mean for the Stock?

  • LifeStance Health Upgrade: LifeStance Health Group (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy) due to a significant increase in earnings estimates, indicating a positive outlook for the company's stock price.

  • Zacks Rating System: The Zacks rating system effectively utilizes earnings estimate revisions to classify stocks, with only the top 5% receiving a "Strong Buy" rating, suggesting that LifeStance Health is well-positioned for potential market-beating returns.

Preview
4.0
05-28TipRanks
3 Best Stocks to Buy Now, 5/28/2025, According to Top Analysts

  • Top Stock Picks: Analysts recommend three stocks as Strong Buys: Nvidia (NVDA) with a 24.30% upside, Strategy (MSTR) with a 56.79% upside, and Lifestance Health Group (LFST) with a 50.17% upside based on recent ratings from top analysts.

  • Analyst Ratings Tool: TipRanks offers an Analyst Top Stocks tool that provides real-time lists of stocks rated by top-ranking analysts, helping investors make informed decisions.

Preview
6.0
05-28TipRanks
“50% Upside” Possible for Lifestance Health Stock (NASDAQ:LFST), Shares Surge

  • Stock Performance and Analyst Upgrade: Lifestance Health Group (LFST) shares rose over 7% after UBS analyst Kevin Caliendo upgraded the stock from Neutral to Buy, maintaining an $8.50 price target that indicates a potential upside of over 54%.

  • Management Changes and Recruitment Strategy: The company has made significant C-suite changes, including appointing a new CTO, while its organic recruiting model is successfully reducing burnout rates among clinicians, contributing positively to its operational stability.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is LifeStance Health Group Inc (LFST) stock price today?

The current price of LFST is 4.22 USD — it has decreased -4.52 % in the last trading day.

arrow icon

What is LifeStance Health Group Inc (LFST)'s business?

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 7,400 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

arrow icon

What is the price predicton of LFST Stock?

Wall Street analysts forecast LFST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFST is 8.70 USD with a low forecast of 8.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is LifeStance Health Group Inc (LFST)'s revenue for the last quarter?

LifeStance Health Group Inc revenue for the last quarter amounts to 332.97M USD, increased 10.83 % YoY.

arrow icon

What is LifeStance Health Group Inc (LFST)'s earnings per share (EPS) for the last quarter?

LifeStance Health Group Inc. EPS for the last quarter amounts to 0.00 USD, decreased -100.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for LifeStance Health Group Inc (LFST)'s fundamentals?

The market is revising Downward the revenue expectations for LifeStance Health Group, Inc. (LFST) for FY2025, with the revenue forecasts being adjusted by -0.23% over the past three months. During the same period, the stock price has changed by -31.49%.
arrow icon

How many employees does LifeStance Health Group Inc (LFST). have?

LifeStance Health Group Inc (LFST) has 10218 emplpoyees as of July 19 2025.

arrow icon

What is LifeStance Health Group Inc (LFST) market cap?

Today LFST has the market capitalization of 1.65B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free